Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Air Displacement Pipettors Empower a New Line of Microbiology Diagnostic Instruments

By BiotechDaily International staff writers
Posted on 23 Dec 2013
Image: The new Cavro Air Displacement Pipettor (ADP) is a compact, pneumatic pipetting solution for easy integration and exceptional liquid handling performance (Photo courtesy of Tecan).
Image: The new Cavro Air Displacement Pipettor (ADP) is a compact, pneumatic pipetting solution for easy integration and exceptional liquid handling performance (Photo courtesy of Tecan).
Image: Cavro ADP modules in the PRELUD instrument enables accurate liquid dispensing ranging from microliters to milliliters (Photo courtesy of Tecan).
Image: Cavro ADP modules in the PRELUD instrument enables accurate liquid dispensing ranging from microliters to milliliters (Photo courtesy of Tecan).
A French manufacturer of microbiology diagnostic instruments had incorporated Swiss-built air displaced pipette units in its new line of liquid handling systems.

Tecan (Männedorf, Switzerland), a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics recently announced that the French microbiological instrument manufacturer i2a (Montpellier, France) would be incorporating its Cavro Air Displacement Pipettor (ADP) into PRELUD, an automated preanalytical instrument for the inoculation of culture plates and preparation of agar susceptibility tests.

The Cavro ADP is a fully programmable pneumatic pipetting module that uses air rather than liquid displacement to aspirate and dispense fluids. The slender design allows the Cavro ADP to be mounted in automated applications with narrow 18 mm spacing between devices. The Cavro ADP is compatible with Tecan’s high quality disposable tips (DiTis) for situations where washing tips between samples is ineffective or impractical.

“We needed something very light and easy to use, and that was capable of pipetting liquid volumes ranging from microliters to milliliters,” said Michel Roch, i2a's PRELUD project manager. “The Cavro ADP was easy to integrate because it operates mechanically without the use of liquids, and it allows precision liquid dispensing. The tip ejector was another highly useful function; we use Tecan’s disposable tips and simply change between 10 microliter, 200 microliter and 1 milliliter tips according to our needs. We were able to integrate the Cavro ADP into PRELUD very quickly and, within two days, we could handle liquids. The reproducibility, precision, and accuracy of the Cavro ADP are good enough for our microbiology application without the need for any further tests or trials. We are very satisfied with our collaboration with Tecan.”

Related Links:
Tecan
i2a 


comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.